Pulling SEC filings + quote and writing the call…
SPRO
Spero Therapeutics, Inc.
Next earnings Aug 10, 2026 · consensus $-0.17 EPS
Last earnings -3.9% on 2026-05-13
$2.21
▼ -3.07%$2.21▼ -22.46%
over 1Y
L $1.83EODHDH $3.04
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-3.1%
1W-24.1%
1M-22.7%
3M-6.0%
YTD-6.0%
1Y-22.5%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Sell
Revenue grew 3292.5% YoY.
The read
Quality fundamentals and an attractive price line up (~158% below fair value) — the rarer case where both the business and the entry look good.
Sources: SEC EDGAR (CIK 0001701108, latest 10-Q filed 2026-05-13) · EODHD · as of 6/23/2026, 2:46:47 AM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.